The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Inducible T-cell co-stimulatory (ICOS) receptor agonist, feladilimab (fela), alone and in combination (combo) with pembrolizumab (P): Results from INDUCE-1 urothelial carcinoma (UC) expansion cohorts (ECs).
 
Arjun Vasant Balar
Honoraria - AstraZeneca/MedImmune; Genentech/Roche; Merck
Consulting or Advisory Role - AstraZeneca/MedImmune; Cerulean Pharma; Dragonfly Therapeutics; Genentech/Roche; GlaxoSmithKline; Incyte; Merck; Nektar; Pfizer/EMD Serono; Seattle Genetics/Astellas
Research Funding - AstraZeneca/MedImmune (Inst); Genentech/Roche (Inst); Merck (Inst); Seagen
 
Victor Moreno
Employment - START
Consulting or Advisory Role - Basilea; Bayer; BMS; Janssen Oncology; Merck; Roche
Speakers' Bureau - Bayer
Research Funding - Abbvie (Inst); ACEA Biosciences (Inst); Adaptimmune (Inst); Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); E-therapeutics (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Menarini (Inst); Merck (Inst); Nanobiotix (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); PsiOxus Therapeutics (Inst); Puma Biotechnology (Inst); Regeneron (Inst); RigonTEC (Inst); Roche (Inst); Sanofi (Inst); Sierra Oncology (Inst); Synthon (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Tesaro (Inst); Transgene (Inst)
Expert Testimony - Medscape/Bayer; Nanobiotix
Travel, Accommodations, Expenses - Sanofi/Regeneron
Other Relationship - BMS
 
Eric Angevin
Consulting or Advisory Role - Celgene; GlaxoSmithKline; MedImmune; Merck Sharp & Dohme; Roche
Research Funding - Abbvie; GlaxoSmithKline; MedImmune; Octimet; Pfizer; Sanofi
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Innate Pharma
 
Hui Kong Gan
Consulting or Advisory Role - BMS; MSD
Research Funding - AbbVie
 
Maria Vieito
Consulting or Advisory Role - Debiopharm Group; Roche; TFS
Travel, Accommodations, Expenses - Merck Serono; Roche
 
Antoine Italiano
Consulting or Advisory Role - Bayer; Daiichi Sankyo; Epizyme; Novartis; Roche; SpringWorks Therapeutics
Research Funding - AstraZeneca; Bayer; Bristol-Myers Squibb; Merck; MSD; Roche
 
Riccardo Danielli
Honoraria - SciClone
Consulting or Advisory Role - SciClone
Speakers' Bureau - Merck Serono
Travel, Accommodations, Expenses - Janssen; SciClone
 
Erminia Massarelli
Honoraria - AstraZeneca; Merck
Consulting or Advisory Role - Genentech/Roche; Merck
Speakers' Bureau - AstraZeneca; Merck
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Merck (Inst); Pfizer (Inst); Tessa Therapeutics (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Merck; Pfizer
 
Frans Opdam
No Relationships to Disclose
 
Michael Jon Chisamore
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Debra Rogan
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Xiao Ji
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Courtney Henry
No Relationships to Disclose
 
Catherine Elizabeth Ellis
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Marc S. Ballas
Employment - GlaxoSmithKline
Leadership - GlaxoSmithKline
Stock and Other Ownership Interests - Bristol-Myers Squibb; GlaxoSmithKline; Moderna Therapeutics
Research Funding - GlaxoSmithKline
Patents, Royalties, Other Intellectual Property - AstraZeneca; GlaxoSmithKline
Travel, Accommodations, Expenses - GlaxoSmithKline
Other Relationship - Abbvie (I)
 
Axel Hoos
Employment - GlaxoSmithKline
Leadership - Imugene; TCR2 Therapeutics
Stock and Other Ownership Interests - GlaxoSmithKline; Imugene; TCR2 Therapeutics
Travel, Accommodations, Expenses - GlaxoSmithKline; Imugene; TCR2 Therapeutics
 
Francesco Ricci
No Relationships to Disclose